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1004.11-20 Changes of the Levels of Secretory Type II 
Phospholipase A2 in Patients With Coronary Artery 
Disease Undergoing Percutaneous Coronary 
intervention 
Pino_Yen, Yi-Heng Li, Wei-Chuan Tsal, Ting-Hsing Chao. Shi-Hong Ghan, Liang-Miin 
Tsai, Jyh-Hong Chen, FACC, National Cheng-Kung University Hospital, Tainan, 
Taiwan, ROC. 
Background: A, phospholipases are a family of enzymes that can hydrolyze phospho- 
lipids at the w-2 position to generate lysophospholipids, and precursors of various pro- 
inflammatory lipid mediators including leukotrienes, prostaglandins. and platelet-activat- 
ing factors. They might be involved in modifying plaque in the artery wall and presented 
as prognostic factors. The circulating levels of secretmy non-pancreatic type II phospho- 
lipase A2 (sPLA,) are increased in various chronic inflammatory diseases, including cor- 
onary artery disease (CAD). These inflammatory markers, as C-reactive protein (CRP) or 
sPLA2. may play a role in the pathogenesis of acute coronary syndrome with the rupture 
and inflammation of an atherosclerotic arterial plaque. The present study was designed 
to evaluate the changes of the levels of sPLAz and other markers after mechanical 
plaque rupture by percutaneous coronary intervention (PCI) in CAD patients. 
Methods and Reeulte: Plasma levels of sPLA* and CRP were measured in 61 consecu- 
tive patients with CAD by enzyme-liked immunoassay. Five serum samples were mea- 
sured. They are: (1) before diagnostic angiography, (2) after diagnostic angiography, (3) 
after PCI, (4) 24-hours after procedure and (5) 46.hours after procedure respectively. 
The sPLA* levels didn’t change after the procedures of diagnostic angiography (207 -t 
125.4 ms/dL vs. 201.9 i 124.6 mg/dL, p = 0.7) and neither did the serum CRP levels (6.0 
f 7.4 mg/dL vs. 4.4 + 4.7 mg/dL, p = 0.10). The levels of sPLA2 significantly increased 
after the coronary intervention (212.3 + 46.9 mg/dL vs. 430.3 * 277.4 mg/dL, p<O.OOOl). 
The levels of CRP didn’t rise up immediately after PCI but elevated significantly later at 
24 hours after intervention (5.02 k 6.62 mg/dL vs. 13.43 i 16.1 mg/dL, p = 0.02). 
Concluelon: Data from the present study had shown that the procedure of PCI might 
result in immediate elevation of circulating levels of sPLA2 following the mechanical dis- 
ruption of coronary plaque. The CRP levels didn’t rise immediately but increased signifi- 
cantly until,24 hours after PCI. These results strongly suggest that sPLA* plays as a pro- 
inflammatory factor and may contribute in the pathogenesis of acute coronary event. 
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1005-2 Late Anglographic and Clinical Findings After Elective 
Placement of the Penta Stent: Results From the PENTA 
Stent Registry 
JeffrevJ.PoDma, David Cox, Naim Farhat, Mark Midei, Alex Schomig, James Hermiller, 
Jeffrey Werner, Marina Sievers, Stan Fink, Tom Linnemeier, Brigham and Women’s 
Hospital, Boston, Massachusetts. 
Background: The MULTI-LINK PENTA coronary stent is the fifth generation MULTI- 
LINKa stent that provides enhanced flexibility, conformability, deliverability, scaffolding, 
and radiopacity over prior generations of stents, in part, due to its variable thickness 
struts (VTS: stent thickness, 0.0036”/0.0049”). Methods: 200 patients with ischemic coro- 
nary artery disease and at least one stenosis > 50% in a native coronary vessel were 
treated with a single comnary intervention using the PENTA stent. Demographics 
included: age, 62.6 years, men 65.5%, diabetes mellitus, 18.5%. The primary clinical 
endpoint of the study was the occurrence of a major in-hospital adverse cardiac event 
(MACE) Including death, myocardial infarction, or urgent revascularization using PTCA 
or CABG. The primary angiographic endpoint was binary restenosis (>50% follow-up 
diameter stenosis) obtained using quantitative angiographic methods. Results: The refer- 
ence vessel diameter was 2.91mm and the minimal lumen diameter (MLD) was 1.01 mm 
yielding a 65% baseline diameter stenosis. The lesion length was 12.90 mm: ACC/AHA 
lesion complexity score was 82 or higher in 03.4% of cases. The in-hospital and 30-day 
MACE rate was 1 .O%. Early events included: target vessel failure, 2.0%: death, 0%; non- 
fatal Q-wave myocardial infarction (Ml), non-fatal non-Q-wave MI, 1.0%; target vessel 
revascularization (NR). 1 .O%. There were no episodes of subacute stent thrombosis 
(SAT). The overall procedure success was 96.0%. The post-procedural % diameter 
stenosis was 3+11%. Six-month angiographic follow-up was obtained in 83.6% of 
patients. The binary restenosis rate was 17.5%. 
Conclusion: The New PENTA stent design is associated with high acute success, low 
MACE, SAT, and NR. Despite complex lesion morphology, a low six-month binary rest- 
enosis was shown. Complete clinical and angiographic evaluation at 6 months will be 
oresented. 
1005-3 Treatment of In-Stent Ftestenosls by Combining Cutting 
Balloon Angloplasty and Vascular Brachytherapy: A 
Report From the RENO Registry 
&&Q&Q& Hristian Roguelov, Edoardo De Benedetti. Philippe Coucke, Sigmund 
Silber, Remo Albiero, Thomas Schiele, Raoul Bonan, Philip Urban, CHUV, Lausanne, 
Switzerlend. 
Background : The Rena Registry tracks all patients who are treated by Beta-Cath 
(Novoste, Brussels) coronary brachytherapy (CBT) in Europe not included in another 
trial. The theoretical advantage of cutting balloon angioplasty over conventional angio- 
plasty prior to CBT is the potential to avoid balloon slipping which may induce geographic 
miss. 
Methods : From April 1999 on, 1111 patients have been included in this Registry. In 166 
patients with in-stent-restenosis a combined approach using cutting balloon angioplasty 
followed by CBT was performed (Groupl). In 712 patients with in-stent-restenosis con- 
ventional PTCA and CBT was perfoned (Group 2). The primary outcome measure was 
major adverse events (defined as a combination of death, myocardial infarction and tar- 
get vessel revascularization) at 6 months. 
Results : The clinical, angiographic and procedural characteristics of Group 1 were as 
follows : mean age was 62+10 years and 123 were male (74.1%) ; 44 patients (27.2%) 
had diabetes and 22 (13.6%) had unstable angina ; 93.7% of lesions were located in 
native coronary arteries ; reference vessel size was 3.2520.39 mm and mean lesion 
length was 17.62t12.02 mm ; radiation treatment was performed with a mean dwell time 
of 4.14k1.47 minutes (mean radiation dose : 20.35t3.10 Gy at a depth of 2mm from the 
source) ; stents were implanted in 14.4% of cases. Procedures were successful in 97.7% 
of cases. During hospitalization, 1 patient died and 1 more patient experienced myocar- 
dial infarction (1.2% adverse events (death, myocardial infarction, target vessel revascu- 
lar for Group 1 versus 1.6% for Group 2 (p=NS). At 6 months follow-up. there was a 
significant advantage in terms of target vessel revascularization for Group 1 (10.2% ver- 
sus 16.6% for Group 2 (p=O.O4) and in terms of the primary outcome measure (adverse 
events) for Group 1 (10.6% versus 19.2% for Group 2 (p=O.Ol)). 
Conclusions: These results indicate the feasibility and safety of the strategy of combining 
cutting balloon angioplasty followed by CBT. They demonstrate additional clinical benefit 
at 6 months follow-up with this strategy compared to CBT and conventional PTCA. 
1005-4 The Impact of Stenting in the Very Elderly 
Pedro J. Colon Ha-, Mark Rubenstein, Francisco Martin, Pedro L. Sdnchez, Lad 
C. Harrell. lgor F. Palacios, Massachusetts General Hospital, Boston, Massachusefts. 
Background: The effectiveness of the current era of percutaneous coronary intervention 
(PCI) characterized by high stent utilization in the very elderly (>75 years) is not well 
established. 
Methods: The immediate and long-term outcomes of 123 consecutive patients >75 
years old who underwent PCI in the current stent era (Group 1) were compared with 
those of 123 gender matched patients >75 years old who underwent PCI in the earlier 
new device era characterized by low stent utilization (Group 2). 
Results: There were no significant differences in age @O+/-4 vs. 60+/-4, p=O.O3) or in 
clinical and angiographic characteristics between the two groups. Stent utilization was 
65% vs. 11% (p=O.OOOl) for Groups 1 and 2 respectively. Although procedural success 
rates for Groups 1 and 2 were similar (95% vs. 91%, p=O.l), post PCI minimal lumen 
diameter was superior for group 1 (2.7 +/- 0.6 mm vs. 1.9 +/- 0.7 mm, p=O.O5). In-hospital 
mortality (0% vs. 7.3%, p=O.O3) and in-hospital MACE (death, Q-wave MI, and emer- 
gency CABG: 0.6% vs. 7.3%, p=O.Ol) were lower for Group 1. At 2 years follow-up, 
Kaplan-Meier analysis demonstrated no significant difference in mortality (15% vs. la%, 
p=o.39), Ml (6% vs. 6%, p=O.30), or CABG (6% vs. 9%. p=O.64) between both groups. 
However the need for repeat PCI was lower in Group 1 (9% vs. 24%, p=O.O07: see Fig- 
ure) 
Conclusion: The use of coronary stenting in the very elderly resulted in significant 
decreases in major in-hospital complications and in the need for repeat PCI at P-years 
follow-up. 
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